Project Details
Project Description
| Status | Active |
|---|---|
| Effective start/end date | 17/06/22 → 16/06/27 |
Keywords
- Randomised clinical trial
- multicentre trial
- treatment safety
- treatment efficacy
- sepsis
- kidney injury
A Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel-Group, Multi-Center Phase 3 Pivotal Trial to Investigate the Efficacy and Safety of Recombinant Human Alkaline Phosphatase for Treatment of Patients with Sepsis- Associated Acute Kidney Injury
- Shehabi, Yahya (Primary Chief Investigator (PCI))
Project: Research